stockrowClearPoint Neuro, Inc. (CLPT) vs Standard BioTools Inc. (LAB)
- ClearPoint Neuro, Inc. CLPT 8.60 −1.04%
- Standard BioTools Inc. LAB 0.63 +1.61%
ClearPoint Neuro, Inc. and Standard BioTools Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. is the larger, with a market value of $278.6M against $245.7M — 1.1× the size. ClearPoint Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 1.8×. Standard BioTools Inc. grew revenue faster over the last twelve months: 35.3% against 32.5%. Standard BioTools Inc. has the higher net margin (157.6% vs −79.4%) and the higher return on invested capital (−54.2% vs −62.8%). Across the 18 metrics below, Standard BioTools Inc. leads on 12 and ClearPoint Neuro, Inc. on 6.
Valuation
Profitability
| Metric | CLPT | LAB | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.39% | 52.18% | 57.76% |
| Operating margin | (70.56%) | (97.47%) | (14.84%) |
| Net margin | (79.43%) | 157.62% | (14.45%) |
| Free cash flow margin | (73.02%) | (77.76%) | (5.70%) |
| Return on equity | (167.52%) | 27.86% | (10.56%) |
| Return on assets | (41.75%) | 22.65% | (17.26%) |
| Return on invested capital | (62.84%) | (54.18%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack